positive likelihood ratio takes values between 1 and infinity, while the negative one takes values between
1 and 0. The positive likelihood ratio is calculated as sensitivity divided into (1 - specificity), or the ratio
of true positives divided into false positives. Negative likelihood ratio is calculated as specificity divided
by (1 - sensitivity), or the ratio of false negatives divided by true negatives. If the likelihood ratio is equal
to 1, the probability of diagnosis is the same before and after applying the test. In this case the test is useless,
it has no discriminating capacity. The farther the value of the likelihood ratio is from 1, the stronger the test
will take us out of the diagnostic “uncertainty zone” (Bravo & Cruz, 2015). When evaluating this parameter
for the Crystal violet technique, an infinite positive likelihood value tells us that this diagnostic test has a
high probability of being positive in samples from patients truly infected with H. pylori. For its part, the
negative likelihood value suggests the low probability that there are false negative values with this
diagnostic test, that is, there is a high probability that the Crystal violet technique will obtain negative
results in samples of patients who they are not infected with H. pylori.
The Accuracy of a diagnostic test is based on the probability that the result of this test correctly predicts the
presence or absence of the disease. The results suggest that the Crystal violet technique has the same
Accuracy as the Giemsa technique in the experimental conditions used in this study, being classified within
the criteria that we established based on its Accuracy as a reliable test, so it could be used in daily clinical
practice ensuring the diagnostic value that until then the Giemsa technique has had (Dore & Pes, 2021).
In Cuba, the Giemsa stain appears to be the preferred stain for the histologic diagnosis of H. pylori because
of its good sensitivity, excellent specificity, lack of technical difficulty in preparation, and relatively low
cost (Nagi & Jahanzeb, 2020). These results obtained suggest that the Crystal violet technique has the same
Accuracy as the Giemsa technique in the experimental conditions used in this study, classifying itself within
the criteria that we established based on its Accuracy as a reliable test, so it could be used in daily clinical
practice, ensuring the diagnostic value that the Giemsa technique has had until then.
Conclusions
The results obtained from the evaluation study of the diagnostic staining test with Crystal violet allow us
to conclude that this technique is effective for the diagnosis of H. pylori in stomach biopsy samples, when
compared with the Giemsa staining technique, which is currently employs.
Bibliographic references
Altman, D. G., & Bland, J. M. (1994). Diagnostic tests. 1: Sensitivity and specificity. BMJ: British Medical
Journal, 308(6943), 1552.
Amuri, H. T., & Al-Nuaimy, W. M. (2022). The Role of Histochemical and Immunohistochemical Methods
for The Detection of Helicobacter Pylori in Chronic Gastritis. Iraqi Postgraduate Medical Journal,
21(1).
Bravo, S., & Cruz, J. P. (2015). Diagnostic accuracy studies: Tools for its Interpretation. Revista Chilena
de Radiología, 21(4), 158-164.
Denic, M., Touati, E., & De Reuse, H. (2020). Pathogenesis of Helicobacter pylori infection. Helicobacter,
25, e12736.
Dore, M. P., & Pes, G. M. (2021). What is new in Helicobacter pylori diagnosis. An overview. Journal of
Clinical Medicine, 10(10), 2091.
Kitazawa, S., Ohno, T., Haraguchi, R., & Kitazawa, R. (2022). Histochemistry, cytochemistry and
epigenetics. Acta Histochemica et Cytochemica, 55(1), 1-7.
Lee, Y. C., Dore, M. P., & Graham, D. Y. (2022). Diagnosis and treatment of Helicobacter pylori infection.
Annual review of medicine, 73, 183-195.
Nagi, A. H., & Jahanzeb, A. (2020). Detection of Helicobacter pylori Through Histochemistry &
Immunofluorescent Staining in Biopsies of Patients with Chronic Gastritis. In Proceedings, 34(4),
pp. 4-9.
Nilles, J., Weiss, J., & Theile, D. (2022). Crystal violet staining is a reliable alternative to bicinchoninic
acid assay-based normalization. BioTechniques, 73(3), 131-135.